Pharmaceutical Executive
May 07, 2009
News Analysis
0
0
As it readies submission for a once-weekly diabetes injectable, Amylin announces that it will trim 35 percent of its sales force and put focus on specialty physicians.
May 07, 2009
News Analysis
0
0
New prescriptions for antiviral treatments get huge boost due to H1N1 epidemic. Numbers exceed those seen during this year's influenza season, and the numbers are climbing.
May 06, 2009
News Analysis
0
0
As the economy continues to retract, fewer biotech companies are finding the funding they need to survive, driving more firms to sell or close shop.
May 06, 2009
News Analysis
0
0
Pharm Exec Europe's Gerhard Symons speaks to Andrew Jones, a senior pharmaceutical analyst with the firm, about the value of introducing a "risk radar" to your organization.